Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis

被引：8
|
作者：
Nafziger, A. N. [1 ]
Bertino, J. S., Jr. [1 ]
机构：
[1] Ordway Res Inst, Inst Drug Dev Ctr, Albany, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 04期
关键词：
D O I：
10.1038/sj.clpt.6100105
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [21] Cytochrome P450 3A - Ontogeny and drug disposition
    de Wildt, SN
    Kearns, GL
    Leeder, JS
    van den Anker, JN
    CLINICAL PHARMACOKINETICS, 1999, 37 (06) : 485 - 505
  • [22] Cytochrome P450 3A polymorphisms and immunosuppressive drugs
    Thervet, E
    Legendre, C
    Beaune, P
    Anglicheau, D
    PHARMACOGENOMICS, 2005, 6 (01) : 37 - 47
  • [23] Significance of the Minor Cytochrome P450 3A Isoforms
    Ann K. Daly
    Clinical Pharmacokinetics, 2006, 45 : 13 - 31
  • [24] Significance of the minor cytochrome P450 3A isoforms
    Daly, AK
    CLINICAL PHARMACOKINETICS, 2006, 45 (01) : 13 - 31
  • [25] Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping
    Lee, JI
    Chaves-Gnecco, D
    Amico, JA
    Kroboth, PD
    Wilson, JW
    Frye, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) : 718 - 728
  • [26] The effects of portal shunts on intestinal cytochrome P450 3A activity - Reply
    Chalasani, N
    Gorski, JC
    Patel, NH
    Hall, SD
    Galinsky, RE
    HEPATOLOGY, 2002, 35 (06) : 1550 - 1551
  • [27] Antitumor activity of methoxymorpholinyl doxorubicin: Potentiation by cytochrome P450 3A metabolism
    Lu, H
    Waxman, DJ
    MOLECULAR PHARMACOLOGY, 2005, 67 (01) : 212 - 219
  • [28] TIME-DEPENDENT SUPPRESSION OF HEPATIC CYTOCHROME-P450 3A (P450 3A) IN THE RAT BY CHRONIC CYCLOSPORINE (CSA) TREATMENT
    BRUNNER, LJ
    KOOP, DR
    BENNETT, WM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1055 - 1055
  • [29] Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans
    Okudaira, Toshiaki
    Kotegawa, Tsutomu
    Imai, Hiromitsu
    Tsutsumi, Kimiko
    Nakano, Shigeyuki
    Ohashi, Kyoichi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (07): : 871 - 876
  • [30] Posttranslational elevation of cytochrome P450 3A levels and activity by dimethyl sulfoxide
    Zangar, RC
    Novak, RF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 353 (01) : 1 - 9
12345